Prognostic impact of epidermal growth factor receptor mutation in grade 3 stage IA lung adenocarcinomas

Abstract Objectives Stage IA adenocarcinomas (LUAD) with high-risk features exhibited an increased recurrence rate, and the role of adjuvant therapy in this population remains controversial. Our study aimed to evaluate the prognostic impact of epidermal growth factor receptor (EGFR) mutation in grad...

Descripció completa

Dades bibliogràfiques

Autors principals:	Haoyao Jiang, Han Lin, Weiyu Pan, Chunlai Lu, Jie Gu, Fengkai Xu, Zongwei Chen, Teng Ma, Di Ge
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2026-05-01
Col·lecció:	World Journal of Surgical Oncology
Matèries:	Lung adenocarcinomas Epidermal growth factor receptor Pathological grading system
Accés en línia:	https://doi.org/10.1186/s12957-026-04411-6
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!